Business Wire

YESWEHACK

10.3.2022 09:02:05 CET | Business Wire | Press release

Share
Telenor Sweden to Use Ethical Hackers to Dial-Up Cybersecurity to the Max in Partnership With YesWeHack

Telenor Sweden has partnered with YesWeHack , Europe’s leading Bug Bounty platform, to identify potential vulnerabilities on its critical telecom infrastructure and protect customer information.

Telenor is a leading telecommunications company across the Nordics and Asia with more than 188 million customers worldwide. It has mobile operations in the Nordics, including Norway, Sweden, Denmark, Finland and in Asia, including Pakistan, Bangladesh, Thailand, Malaysia, and Myanmar. Connecting customers to what matters most has been the core of its business for more than 160 years.

Telenor’s wholly owned subsidiary, Telenor Sweden, is one of the largest mobile operator in the country and provider of fixed broadband services to the consumer and business markets in Sweden.

Telecom companies maintain and operate critical communications infrastructure. This is used to transmit large amounts of sensitive consumer and business data, due to which cyberattacks against the industry are soaring. Meanwhile, the rapid advancements of new technologies such as the Internet of Things (IoT) and 5G dramatically increase the potential attack surface and threat landscape for a telco.

To protect customer data and the security of its critical infrastructure, Telenor is investing in security capabilities across its organisation as well as with its suppliers and third-party providers. It ensures the same level of control over data and infrastructure, independent of operating – or business model.

One such initiative is crowdsourcing security through a bug bounty program with YesWeHack to identify security gaps and ensure adequate data protection. Crowdsourced security will help Telenor Sweden access a diverse range of security researchers, also called hunters, with unique specialisations and in-depth industry knowledge.

“The partnership with YesWeHack is one of the ways we work with security and maybe one of the most important ones in our proactive work to stop cybercriminals. The return on investment is huge since we get access to thousands of security researchers while only paying a fraction of the cost it would take to recruit them all individually,” said Ulf Andersson, Head of Information Security at Telenor Sweden. “We are now planning to level up both the private and public program to make it even more attractive and generate more reports,” he added.

Telenor Sweden had started with a private bug bounty program where YesWeHack invited selected researchers to hack it’s infrastructure. This was followed by a public bug bounty program where the telco is now being scrutinised by the entire YesWeHack community, representing more than 35,000 global cybersecurity researchers.

“Through the YesWeHack bug bounty program, we are connected to one of the finest global networks of hackers to help us find security gaps in our infrastructure. It's all about finding vulnerabilities before anyone else. By being proactive and allowing the hacking of our infrastructure, we can find weaknesses before the criminals do and fix them,” said Marcus Lundblad, Security Engineer at Telenor Sweden.

By reducing security gaps and ensuring adequate data protection, Telenor Sweden gives its customers the comfort to share information and allow them to reap the benefits of the data-driven economy.

“Protecting people in their digital life with security at the foundation is the core value of Telenor,” said Guillaume Vassault-Houlière, CEO and Co-Founder of YesWeHack. “Telenor Sweden has achieved the position of a trusted and secure provider in all markets because of its focus on customer data protection and by defending its critical infrastructure by adopting game-changing solutions such as bug bounty,” he added.

Cybersecurity experts from Telenor Sweden will share best practices on guarding against cyber threats in a webinar on March 17th 2022. They will also share why the organisation has put bug bounty at the core of its security posture and will detail the clear benefits of a platform-driven, results-oriented and crowdsourced approach to security audits. For more information and registration visit our blog .

ABOUT YESWEHACK

Founded in 2015, YesWeHack is the #1 European Bug Bounty & VDP Platform. YesWeHack offers companies an innovative approach to cybersecurity with Bug Bounty (pay-per-vulnerability discovered), connecting more than 35,000 cybersecurity experts (ethical hackers) across 170 countries with organisations to secure their exposed scopes and reporting vulnerabilities in their websites, mobile apps, infrastructure and connected devices. YesWeHack runs private and public programs for hundreds of organisations worldwide in compliance with the strictest European regulations.

In addition to the Bug Bounty platform, YesWeHack also offers support in creating a Vulnerability Disclosure Policy (VDP), a learning platform for ethical hackers called Dojo and a training platform for educational institutions, YesWeHackEDU. For more information: www.yeswehack.com

Link:

ClickThru

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Galderma Receives U.S. FDA Approval for Differin® Epiduo® Acne Gel Prescription-to-OTC Switch22.5.2026 18:25:00 CEST | Press release

A unique Prescription-to-OTC switch in acne care, this approval expands access to a dermatologist-trusted, prescription-strength treatment for millions of acne sufferers ages 12 years and older Backed by more than 15 years of real-world dermatologist use and a robust clinical research program, this milestone demonstrates the depth of science behind the Differin® and Epiduo® heritage Adapalene plus benzoyl peroxide (0.1/2.5%) was the first FDA-approved, stable, fixed- dose prescription acne treatment to combine of benzoyl peroxide with a retinoid, and is now available over-the-counter The formulation is engineered to target multiple causes of acne more effectively than either of its individual active ingredients alone Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) us

Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 16:18:00 CEST | Press release

Avanzanite will commercialise and distribute PYRUKYND in Europe under its exclusive agreement with Agios Avanzanite is committed to collaborating with local authorities in the EU to enable access to PYRUKYND for adult patients with thalassaemia Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full releas

ICE Brent and ICE WTI Perpetual Futures to Launch on OKX22.5.2026 14:30:00 CEST | Press release

OKX, a blockchain technology and trading company serving more than 120 million customers globally,and Intercontinental Exchange (NYSE: ICE), one of the world's leading providers of financial market technology and data powering global capital markets including the New York Stock Exchange, today announced plans for OKX to launch perpetual futures based on ICE's Brent Crude and WTI Crude energy benchmarks. The products are expected to be available to trade on OKX’s platform in jurisdictions where OKX is licensed to offer perpetual futures products. The new OKX contracts represent a major step forward in expanding regulated access to global commodity markets through digital asset infrastructure. This first product collaboration between OKX and ICE comes after the companies established a strategic relationship in March 2026. ICE operates some of the world’s leading exchanges, clearing houses and market data services across energy, commodities, fixed income and equities markets. ICE’s future

Enhertu® Recommended for Approval in the EU by CHMP for Patients with Previously Treated HER2 Positive Metastatic Solid Tumors22.5.2026 14:00:00 CEST | Press release

Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the treatment of adult patients with unresectable or metastatic HER2 positive (immunohistochemistry [IHC] 3+) solid tumors who have received prior treatment and who have no satisfactory treatment options. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from patients with HER2 positive (IHC 3+) tumors in three phase 2 trials including DESTINY-PanTumor02,DESTINY-Lung01 andDESTINY-CRC02 where Enhertu demonstrated clinically meaningful responses across a broad range of tumors. The recommendation will now be reviewed by the European Commission, which has the authority

Future Health Challenge Awards USD 300,000 to Early Detection and Population Health Sensing Tools on Sidelines of World Health Assembly22.5.2026 13:45:00 CEST | Press release

Global teams recognised in the Future Health Challenge for solutions designed to detect health risks earlier and support faster health system decisions Future Health – A Global Initiative by Abu Dhabi and MIT Solve announce the winners of the inaugural Future Health ChallengeWinning solution equips frontline health workers in low-resource settings with mobile clinical decision-support tools, enabling earlier detection and more effective care deliveryTeams competed for a USD 200,000 grand prize and two USD 50,000 runner-up awards on the sidelines of the 79th World Health Assembly in GenevaWinners recognised for solutions advancing anticipatory, data-driven health systems Three global teams developing early detection and real-time population health monitoring solutions have secured a total of USD 300,000 on the sidelines of the 79th World Health Assembly. The winning solutions address critical challenges in early detection, continuous population insight and more timely decision making, s

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye